Kewaunee Scientific (NASDAQ:KEQU) Stock Crosses Below 200 Day Moving Average - Time to Sell?

Key Points

• Kewaunee Scientific shares fell below their 200-day moving average, priced at $45.72, trading as low as $45.02 during recent sessions, highlighting a potential bearish trend.
• Wall Street Zen upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating, suggesting increased investor confidence in the stock's future performance.
• The company's quarterly earnings report revealed earnings per share of $1.10 and a revenue of $71.10 million, indicating a return on equity of 25.65%, which reflects solid profitability metrics.

Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report)'s stock price crossed below its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of $45.72 and traded as low as $45.02. Kewaunee Scientific shares last traded at $45.76, with a volume of 5,630 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a report on Saturday, July 5th.

Kewaunee Scientific Stock Performance

The company has a debt-to-equity ratio of 0.88, a current ratio of 2.32 and a quick ratio of 1.59. The company has a market capitalization of $126.31 million, a price-to-earnings ratio of 10.66 and a beta of 0.75. The stock has a 50 day simple moving average of $54.51 and a two-hundred day simple moving average of $45.58.

Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last posted its quarterly earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The company had revenue of $71.10 million for the quarter.

Insiders Place Their Bets

In other Kewaunee Scientific news, CFO Donald T. Gardner III sold 3,000 shares of the firm's stock in a transaction on Thursday, July 24th. The stock was sold at an average price of $58.59, for a total value of $175,770.00. Following the sale, the chief financial officer directly owned 14,564 shares in the company, valued at $853,304.76. This trade represents a 17.08% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. 13.30% of the stock is currently owned by corporate insiders.

Institutional Trading of Kewaunee Scientific

Hedge funds and other institutional investors have recently bought and sold shares of the business. Jane Street Group LLC acquired a new stake in Kewaunee Scientific in the fourth quarter valued at $300,000. Punch & Associates Investment Management Inc. purchased a new stake in shares of Kewaunee Scientific in the 1st quarter valued at about $788,000. OMERS ADMINISTRATION Corp purchased a new stake in shares of Kewaunee Scientific in the 1st quarter valued at about $284,000. American Century Companies Inc. lifted its holdings in shares of Kewaunee Scientific by 43.4% in the 1st quarter. American Century Companies Inc. now owns 49,182 shares of the technology company's stock valued at $1,937,000 after purchasing an additional 14,889 shares during the last quarter. Finally, IFP Advisors Inc lifted its holdings in shares of Kewaunee Scientific by 61.5% in the 1st quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock valued at $37,000 after purchasing an additional 360 shares during the last quarter. 32.69% of the stock is currently owned by institutional investors and hedge funds.

Kewaunee Scientific Company Profile

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.